chr17-75830364-T-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_199242.3(UNC13D):​c.2828A>G​(p.Asn943Ser) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000533 in 1,593,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0015 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00043 ( 0 hom. )

Consequence

UNC13D
NM_199242.3 missense, splice_region

Scores

2
7
10
Splicing: ADA: 0.1588
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 6.58

Publications

5 publications found
Variant links:
Genes affected
UNC13D (HGNC:23147): (unc-13 homolog D) This gene encodes a protein that is a member of the UNC13 family, containing similar domain structure as other family members but lacking an N-terminal phorbol ester-binding C1 domain present in other Munc13 proteins. The protein appears to play a role in vesicle maturation during exocytosis and is involved in regulation of cytolytic granules secretion. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis type 3, a genetically heterogeneous, rare autosomal recessive disorder. [provided by RefSeq, Jul 2008]
UNC13D Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.016261786).
BP6
Variant 17-75830364-T-C is Benign according to our data. Variant chr17-75830364-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 533103.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00152 (232/152318) while in subpopulation AFR AF = 0.00481 (200/41568). AF 95% confidence interval is 0.00426. There are 0 homozygotes in GnomAd4. There are 106 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UNC13DNM_199242.3 linkc.2828A>G p.Asn943Ser missense_variant, splice_region_variant Exon 29 of 32 ENST00000207549.9 NP_954712.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UNC13DENST00000207549.9 linkc.2828A>G p.Asn943Ser missense_variant, splice_region_variant Exon 29 of 32 1 NM_199242.3 ENSP00000207549.3

Frequencies

GnomAD3 genomes
AF:
0.00149
AC:
227
AN:
152200
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00468
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000528
AC:
114
AN:
215958
AF XY:
0.000507
show subpopulations
Gnomad AFR exome
AF:
0.00542
Gnomad AMR exome
AF:
0.000228
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000313
Gnomad OTH exome
AF:
0.000558
GnomAD4 exome
AF:
0.000428
AC:
617
AN:
1441320
Hom.:
0
Cov.:
34
AF XY:
0.000401
AC XY:
287
AN XY:
714998
show subpopulations
African (AFR)
AF:
0.00443
AC:
147
AN:
33216
American (AMR)
AF:
0.000289
AC:
12
AN:
41538
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25650
East Asian (EAS)
AF:
0.0000256
AC:
1
AN:
39038
South Asian (SAS)
AF:
0.0000723
AC:
6
AN:
82980
European-Finnish (FIN)
AF:
0.0000195
AC:
1
AN:
51378
Middle Eastern (MID)
AF:
0.000242
AC:
1
AN:
4126
European-Non Finnish (NFE)
AF:
0.000362
AC:
400
AN:
1103886
Other (OTH)
AF:
0.000823
AC:
49
AN:
59508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
45
90
136
181
226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00152
AC:
232
AN:
152318
Hom.:
0
Cov.:
33
AF XY:
0.00142
AC XY:
106
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.00481
AC:
200
AN:
41568
American (AMR)
AF:
0.000588
AC:
9
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68034
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000605
Hom.:
1
Bravo
AF:
0.00173
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00569
AC:
25
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000565
AC:
68
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jan 22, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Observed as a single heterozygous variant in two patients with a clinically suspected diagnosis of hemophagocytic lymphohistiocytosis both of whom also harbored a heterozygous variant in the STXBP2 gene (PMID: 24916509); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36681659, 24916509) -

Familial hemophagocytic lymphohistiocytosis 3 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.31
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.58
D;.
Eigen
Uncertain
0.19
Eigen_PC
Benign
0.19
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.94
D;D
M_CAP
Benign
0.071
D
MetaRNN
Benign
0.016
T;T
MetaSVM
Benign
-0.73
T
MutationAssessor
Benign
2.0
M;M
PhyloP100
6.6
PrimateAI
Uncertain
0.58
T
PROVEAN
Pathogenic
-4.9
D;D
REVEL
Benign
0.28
Sift
Uncertain
0.0040
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.91
P;.
Vest4
0.63
MVP
0.81
MPC
0.43
ClinPred
0.051
T
GERP RS
4.9
PromoterAI
-0.094
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.48
gMVP
0.41
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.16
dbscSNV1_RF
Benign
0.39
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147748627; hg19: chr17-73826445; API